Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286933263> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4286933263 endingPage "1122" @default.
- W4286933263 startingPage "1117" @default.
- W4286933263 abstract "Intraoperative acridine orange-photodynamic therapy (AO-PDT) and cribriform plate irradiation are used to treat canine intranasal tumors. The purpose of this study was to evaluate the effects of AO-PDT on intranasal tumors and the recurrence rate of tumors after this treatment. Treatments with AO-PDT were performed on 38 dogs through a narrow window of the dorsal nasal cavity. The median progression-free interval was 12 mo and recurrence was detected in 21 dogs. Based on computed tomography, recurrence in 16 dogs was biased to the following areas: lateral (n = 10), medial (n = 2), ventral (n = 0), rostral (n = 0), and caudal (n = 8). Side effects were mild and included subcutaneous emphysema and rhinitis. The median survival time was 24 mo. Although AO-PDT with cribriform irradiation is an effective treatment for intranasal tumors, AO-PDT techniques should be improved to treat the nasal cavity more uniformly and thoroughly.Analyse de récurrence de la thérapie photodynamique peropératoire à l’acridine orange pour des chiens atteints de tumeurs intranasales. La thérapie photodynamique peropératoire à l’acridine orange (AO-PDT) et l’irradiation de la plaque cribriforme sont utilisées pour traiter les tumeurs intranasales canines. Le but de cette étude était d’évaluer les effets de l’AO-PDT sur les tumeurs intranasales et le taux de récidive des tumeurs après ce traitement. Des traitements avec AO-PDT ont été effectués sur 38 chiens à travers une fenêtre étroite de la cavité nasale dorsale. L’intervalle médian sans progression était de 12 mois et une récidive a été détectée chez 21 chiens. Sur la base de la tomodensitométrie, la récidive chez 16 chiens était biaisée dans les zones suivantes : latérale (n = 10), médiale (n = 2), ventrale (n = 0), rostrale (n = 0) et caudale (n = 8). Les effets secondaires étaient légers et comprenaient l’emphysème sous-cutané et la rhinite. La durée médiane de survie était de 24 mois. Bien que l’AO-PDT avec irradiation de la plaque cribriforme soit un traitement efficace pour les tumeurs intranasales, les techniques d’AO-PDT devraient être améliorées pour traiter la cavité nasale de manière plus uniforme et plus complète.(Traduit par Dr Serge Messier)." @default.
- W4286933263 created "2022-07-25" @default.
- W4286933263 creator A5011436051 @default.
- W4286933263 creator A5020145783 @default.
- W4286933263 creator A5021211693 @default.
- W4286933263 creator A5036917508 @default.
- W4286933263 creator A5046569521 @default.
- W4286933263 creator A5052699212 @default.
- W4286933263 creator A5067484613 @default.
- W4286933263 creator A5088362347 @default.
- W4286933263 date "2021-10-01" @default.
- W4286933263 modified "2023-09-29" @default.
- W4286933263 title "Recurrence analysis of intraoperative acridine orange-photodynamic therapy for dogs with intranasal tumors." @default.
- W4286933263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34602642" @default.
- W4286933263 hasPublicationYear "2021" @default.
- W4286933263 type Work @default.
- W4286933263 citedByCount "0" @default.
- W4286933263 crossrefType "journal-article" @default.
- W4286933263 hasAuthorship W4286933263A5011436051 @default.
- W4286933263 hasAuthorship W4286933263A5020145783 @default.
- W4286933263 hasAuthorship W4286933263A5021211693 @default.
- W4286933263 hasAuthorship W4286933263A5036917508 @default.
- W4286933263 hasAuthorship W4286933263A5046569521 @default.
- W4286933263 hasAuthorship W4286933263A5052699212 @default.
- W4286933263 hasAuthorship W4286933263A5067484613 @default.
- W4286933263 hasAuthorship W4286933263A5088362347 @default.
- W4286933263 hasConcept C141071460 @default.
- W4286933263 hasConcept C142724271 @default.
- W4286933263 hasConcept C178790620 @default.
- W4286933263 hasConcept C185592680 @default.
- W4286933263 hasConcept C203014093 @default.
- W4286933263 hasConcept C2778411198 @default.
- W4286933263 hasConcept C2778801703 @default.
- W4286933263 hasConcept C2779102032 @default.
- W4286933263 hasConcept C2781323092 @default.
- W4286933263 hasConcept C71924100 @default.
- W4286933263 hasConcept C74864618 @default.
- W4286933263 hasConcept C85663871 @default.
- W4286933263 hasConceptScore W4286933263C141071460 @default.
- W4286933263 hasConceptScore W4286933263C142724271 @default.
- W4286933263 hasConceptScore W4286933263C178790620 @default.
- W4286933263 hasConceptScore W4286933263C185592680 @default.
- W4286933263 hasConceptScore W4286933263C203014093 @default.
- W4286933263 hasConceptScore W4286933263C2778411198 @default.
- W4286933263 hasConceptScore W4286933263C2778801703 @default.
- W4286933263 hasConceptScore W4286933263C2779102032 @default.
- W4286933263 hasConceptScore W4286933263C2781323092 @default.
- W4286933263 hasConceptScore W4286933263C71924100 @default.
- W4286933263 hasConceptScore W4286933263C74864618 @default.
- W4286933263 hasConceptScore W4286933263C85663871 @default.
- W4286933263 hasIssue "10" @default.
- W4286933263 hasLocation W42869332631 @default.
- W4286933263 hasOpenAccess W4286933263 @default.
- W4286933263 hasPrimaryLocation W42869332631 @default.
- W4286933263 hasRelatedWork W11160634 @default.
- W4286933263 hasRelatedWork W11222335 @default.
- W4286933263 hasRelatedWork W1368622 @default.
- W4286933263 hasRelatedWork W14860793 @default.
- W4286933263 hasRelatedWork W18729769 @default.
- W4286933263 hasRelatedWork W19945932 @default.
- W4286933263 hasRelatedWork W21850709 @default.
- W4286933263 hasRelatedWork W2300685 @default.
- W4286933263 hasRelatedWork W3659627 @default.
- W4286933263 hasRelatedWork W4139285 @default.
- W4286933263 hasVolume "62" @default.
- W4286933263 isParatext "false" @default.
- W4286933263 isRetracted "false" @default.
- W4286933263 workType "article" @default.